Search

Your search keyword '"Seeger, John D."' showing total 591 results

Search Constraints

Start Over You searched for: Author "Seeger, John D." Remove constraint Author: "Seeger, John D."
591 results on '"Seeger, John D."'

Search Results

1. Incidence rates of thrombosis with thrombocytopenia syndrome (TTS) among adults in United States commercial and Medicare claims databases, 2017–2020

2. Effectiveness of monovalent COVID-19 booster/additional vaccine doses in the United States

4. Effectiveness of BNT162b2 COVID-19 primary series vaccination in children aged 5–17 years in the United States: a cohort study

7. Lessons learned from a multi‐data source research collaboration: The mirabegron post‐authorization safety study program

8. Evaluation of Febrile Seizure Risk Following Ancestral Monovalent COVID-19 mRNA Vaccination Among U.S. Children Aged 2-5 Years

10. Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases

14. Risk of Adverse Events Following Monovalent Third or Booster Dose of COVID-19 mRNA Vaccination in U.S. Adults Ages 18 Years and Older

16. Safety of Monovalent BNT162b2 (Pfizer–BioNTech), mRNA–1273 (Moderna), and NVX–CoV2373 (Novavax) COVID–19 Vaccines in US Children Aged 6 months to 17 years

18. Pragmatic guidance for embedding pragmatic clinical trials in health plans: Large simple trials aren’t so simple

19. Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 Years

20. Use of Immunization Information Systems in Ascertainment of COVID-19 Vaccinations for Claims-Based Vaccine Safety and Effectiveness Studies

21. Abstract 13154: Cardiovascular Risk in Users of Mirabegron Relative to Users of Antimuscarinic Treatments for Overactive Bladder: Findings From a Non-interventional, Real-world Data Safety Study

22. Cervical High-Grade Squamous Intraepithelial Lesion Burden and Standard of Care Treatment Effectiveness and Safety in the United States, 2008–2018: The EACH-WOMAN Project

23. Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019–2020

27. List of Contributors

29. Results of safety monitoring of BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine in U.S. children aged 5-17 years

39. Treatment characteristics among patients with binge-eating disorder: an electronic health records analysis.

45. Delayed pregnancy detection and return to fertility with extended levonorgestrel‐containing oral contraceptives: A real world setting cohort study.

50. Elevated Risk of Myocarditis/Pericarditis Following COVID-19 mRNA Vaccination in the United States

Catalog

Books, media, physical & digital resources